ArticleCancers2026

Real-World Safety Profile of Adjuvant Abemaciclib in HR+/HER2- Early Breast Cancer.

Maria Pimenta Macedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.